Rapid-Growth Firms, Venture Capital Prospects Surveyed For Device Industry
This article was originally published in The Gray Sheet
Executive Summary
The medical device industry should track its universe of fast-growing, publicly held companies, since a decline in number may signal a negative effect on innovation, The Lewin Group recommends in its fourth report to AdvaMed, released June 18